Babaamaajimowinan (Telling of news in different places)
Patients who used Medtronic insulin pumps to treat their diabetes went to the hospital 27 percent fewer times over the course of a year compared to diabetics who used multiple daily injections to manage their blood-sugar levels, an analysis of UnitedHealthcare insurance members has found.
The analysis, funded and run by the two Minnesota companies, helps to show that investments in Medtronic’s user-run insulin pumps can create “value” by improving patient health and preventing costly hospital admissions down the line.
Reader Comments(0)